Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Alessandra Aparecida Paz"'
Autor:
Tatiana Schnorr Silva, Jaqueline Driemeyer Correia Horvath, Mariana Pinto Pereira, Caroline Nespolo de David, Dora Fraga Vargas, Lisandra Della Costa Rigoni, Ivaine Tais Sauthier Sartor, Luciane Beatriz Kern, Priscila de Oliveira da Silva, Alessandra Aparecida Paz, Liane Esteves Daudt, Claudia Caceres Astigarraga
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 3, Pp 242-249 (2024)
Introduction: The time elapsed from diagnosis to hematopoietic stem cell transplantation (HSCT) is influenced by numerous factors. In Brazil, patients using the public health system are also dependent on the availability of HSCT-specific beds in the
Externí odkaz:
https://doaj.org/article/50f6f6ee61594f08a10153ec6a98d2d9
Autor:
Dora Fraga Vargas, Mariana Pinto Pereira, Tatiana Schnorr Silva, Caroline Nespolo de David, Alessandra Aparecida Paz, Claudia Caceres Astigarraga
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 2, Pp 182-187 (2023)
Introduction: Although extracorporeal photopheresis (ECP) is a promising second-line therapy in the treatment of chronic graft-versus-host disease (cGVHD), its use is limited by its high cost. This study aims to describe the clinical evolution of pat
Externí odkaz:
https://doaj.org/article/dcab946377174a37877cb6b5e3debf3b
Autor:
Vitória Brum da Silva Nunes, Camila Kehl Dias, Juliete Nathali Scholl, Alexia Nedel Sant’Ana, Amanda de Fraga Dias, Mariela Granero Farias, Ana Paula Alegretti, Monalisa Sosnoski, Liane Esteves Daudt, Mariana Bohns Michalowski, Ana Maria Oliveira Battastini, Alessandra Aparecida Paz, Fabrício Figueiró
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-15 (2022)
Abstract Purpose Although risk-stratified chemotherapy regimens improve B-cell acute lymphoblastic leukemia (B-ALL) clinical outcome, relapse occurs in a significant number of cases. The identification of new therapeutic targets as well as prognostic
Externí odkaz:
https://doaj.org/article/3a581ca919d8488aa265a987c716ea9d
Autor:
Fabiane Spagnol, Mariela Granero Farias, Ebellins Tabares Calvache, Pâmela Portela da Silva, Tahiane de Brum Soares, Cristiane Seganfredo Weber, Alessandra Aparecida Paz
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp 7-8 (2023)
As síndromes mielodisplásicas (SMD) são doenças clonais caracterizadas por falência da medula óssea (MO) e aumento do risco de transformação em leucemia mieloide aguda (LMA). A leucemia linfocítica crônica (LLC) é uma das leucemias mais co
Externí odkaz:
https://doaj.org/article/ff542b38e698451690d5bb73b2d6b748
Autor:
Jóice Merzoni, Gisele Menezes Ewald, Alessandra Aparecida Paz, Liane Esteves Daudt, Luiz Fernando Job Jobim
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 5, Pp 369-372 (2014)
Hematopoietic stem cell transplantation is the curative option for patients with myelodysplastic syndrome; however, it requires a long post-transplantation follow-up. A 53-year-old woman with a diagnosis of myelodysplastic syndrome underwent related
Externí odkaz:
https://doaj.org/article/533cd8cff92d4f9aab1f1db346ddac82
Autor:
Lillian Gonçalves Campos, Alessandra Aparecida Paz, Lucia Mariano da Rocha Silla, Liane Esteves Daudt
Publikováno v:
Clinical and Biomedical Research, Vol 29, Iss 2 (2009)
Introdução: O transplante de células-tronco hematopoiéticas (TCTH) alogênico é um procedimento que oferece um potencial de cura para doenças hematológicas malignas e benignas. O benefício da técnica está especialmente relacionado ao aument
Externí odkaz:
https://doaj.org/article/e8fba5a986254d378b08fd611ea8b656
Autor:
Vitória Brum, da Silva Nunes, Camila Kehl, Dias, Marco Antônio, De Bastiani, Mariela Granero, Farias, Fabiane, Spagnol, Ana Paula, Alegretti, Liane Esteves, Daudt, Mariana Bohns, Michalowski, Ana Maria Oliveira, Battastini, Alessandra Aparecida, Paz, Fabrício, Figueiró
Publikováno v:
Purinergic Signal
The risk stratification of B-acute lymphoblastic leukemia (B-ALL) is based on clinical and biological factors. However, B-ALL has significant biological and clinical heterogeneity and 50% of B-ALL patients do not have defined prognostic markers. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b086a466ccd8f4b4714aec2c169ee747
https://doi.org/10.1007/s11302-022-09841-x
https://doi.org/10.1007/s11302-022-09841-x
Autor:
Bruna Pochmann Zambonato, Maria Aperecida Lima da Silva, Bruna A. Corrêa, Alini Vargas, Laurence J.N. Cooper, Jóice Merzoni, Helen Huls, Juliana Nobrega, Dean A. Lee, Bruna Amorin, Ianae Wilke, Fernanda Fetter Scherer, Leo Sekine, Lucia Mariano da Rocha Silla, Alessandra Aparecida Paz, Annelise Pezzi, Vanessa de Souza Valim
Publikováno v:
British Journal of Haematology. 195:710-721
Patients with acute myeloid leukaemia (AML) have a five-year survival rate of 28·7%. Natural killer (NK)-cell have anti-leukaemic activity. Here, we report on a series of 13 patients with high-risk R/R AML, treated with repeated infusions of double-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e21994770313c718ac4e41cc4aaab3c
https://doi.org/10.1111/bjh.17751
https://doi.org/10.1111/bjh.17751
Autor:
Philip Bachour, Mair Pedro de Souza, Rosane Bittencourt, Samir Kanaan Nabhan, Otavio C. G. Baiocchi, Alessandra Aparecida Paz, Decio Lerner, Camila Manca, Leila Pessoa de Melo
Publikováno v:
JBMTCT. 2:101-108
THE BRAZILIAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (SBTMO) PRESENTS THE BRAZILIAN GUIDELINES ON HEMATOPOIETIC STEM CELL TRANSPLANTATION
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b1c761b036d53ab950cba9b42a80817
https://doi.org/10.46765/2675-374x.2021v4n1p101-108
https://doi.org/10.46765/2675-374x.2021v4n1p101-108
Autor:
Vaneuza Araujo Moreira Funke, Samantha Nichele, Samir Kanaan Nabhan, Adriana Seber, Vergilio A.R. Colturato, Liane Esteves Daudt, Gisele Loth, Elias Hallack Atta, Belinda Pinto Simões, Juliana Folloni Fernandes, José Salvador Rodrigues de Oliveira, Mary E.D. Flowers, Andreza Alice Feitosa Ribeiro, Ana Luiza Melo Rodrigues, Luiz Guilherme Darrigo Junior, Leonardo Javier Arcuri, Rodolfo Calixto, Alessandra Araujo Gomes, Nelson Hamerschlak, Renato Cunha, Vanderson Rocha, Carmem Bonfim, Carlos Eduardo Sá Araújo, Celso Arrais-Rodrigues, Alessandra Aparecida Paz, Ricardo Pasquini
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:2311-2317
Severe aplastic anemia (SAA) is a life-threatening disease that can be cured with allogeneic cell transplantation (HCT). Haploidentical donor transplantation with post-transplantation cyclophosphamide (haplo-PTCy) is an option for patients lacking an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e937c135238b92f0d0af0ea66bf57970
https://doi.org/10.1016/j.bbmt.2020.09.007
https://doi.org/10.1016/j.bbmt.2020.09.007